Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
1.450
-0.010 (-0.68%)
Aug 14, 2025, 11:32 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Regulatory Ribonucleic Acid-based Therapeutics
350.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
350.00K